Natera Q3 2021 Earnings Report
Key Takeaways
Natera reported a 61.1% increase in total revenue, reaching $158.1 million, driven by a 61.5% increase in product revenues and a rise in test volumes. The company processed approximately 407,300 tests, with gross profit increasing to $76.7 million. However, the net loss was $151.3 million, or ($1.63) per diluted share, compared to a net loss of $58.3 million in the same period last year.
Total revenues increased by 61.1% to $158.1 million compared to Q3 2020.
Product revenues grew by 61.5% to $150.7 million compared to Q3 2020.
Approximately 407,300 tests were processed in Q3 2021.
Gross profit increased to $76.7 million, with a gross margin of 48.5%.
Natera
Natera
Forward Guidance
Natera anticipates 2021 total revenue of $615 million to $625 million; 2021 gross margin to be approximately 49% to 52% of revenues; selling, general and administrative costs to be approximately $500 million to $520 million; research and development costs to be $240 million to $260 million, and net cash consumption to be $300 million to $340 million.